These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9247484

  • 1. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells.
    Bataller R, Nicolás JM, Ginès P, Esteve A, Nieves Görbig M, Garcia-Ramallo E, Pinzani M, Ros J, Jiménez W, Thomas AP, Arroyo V, Rodés J.
    Gastroenterology; 1997 Aug; 113(2):615-24. PubMed ID: 9247484
    [Abstract] [Full Text] [Related]

  • 2. Simvastatin inhibits the cellular signaling and proliferative action of arginine vasopressin in cultured rat glomerular mesangial cells.
    Ishikawa S, Kawasumi M, Saito T.
    Endocrinology; 1995 May; 136(5):1954-61. PubMed ID: 7720643
    [Abstract] [Full Text] [Related]

  • 3. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
    Serradeil-Le Gal C, Herbert JM, Delisee C, Schaeffer P, Raufaste D, Garcia C, Dol F, Marty E, Maffrand JP, Le Fur G.
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H404-10. PubMed ID: 7840290
    [Abstract] [Full Text] [Related]

  • 4. Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte.
    Tahara A, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.
    Cardiovasc Res; 1998 Apr; 38(1):198-205. PubMed ID: 9683922
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of BQ-123 on endothelin-1-stimulated mitogen-activated protein kinase and cell growth of rat vascular smooth muscle cells.
    Guo X, Okada K, Fujita N, Ishikawa S, Komatsu N, Saito T.
    Hypertens Res; 1996 Mar; 19(1):23-30. PubMed ID: 8829820
    [Abstract] [Full Text] [Related]

  • 6. Arginine vasopressin, via activation of post-junctional V1 receptors, induces contractile effects in mouse distal colon.
    Mastropaolo M, Zizzo MG, Auteri M, Mulè F, Serio R.
    Regul Pept; 2013 Nov 10; 187():29-34. PubMed ID: 24185041
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of arginine vasopressin and oxytocin in cell culture systems.
    Briner VA, Tsai P, Choong HL, Schrier RW.
    Am J Physiol; 1992 Aug 10; 263(2 Pt 2):F222-7. PubMed ID: 1510120
    [Abstract] [Full Text] [Related]

  • 8. Arginine vasopressin stimulates protein synthesis but not proliferation of cultured vascular endothelial cells.
    Simon JS, Baum JS, Moore SA, Kasson BG.
    J Cardiovasc Pharmacol; 1995 Mar 10; 25(3):368-75. PubMed ID: 7769800
    [Abstract] [Full Text] [Related]

  • 9. Cellular signaling and proliferative action of AVP in mesangium of SHR: effect of low density lipoprotein.
    Ishikawa S, Kusaka I, Higashiyama M, Nagasaka S, Saito T, Honda K, Saito T.
    Kidney Int; 1996 Nov 10; 50(5):1506-14. PubMed ID: 8914016
    [Abstract] [Full Text] [Related]

  • 10. Vasopressin stimulates DNA synthesis in cultured rat hepatocytes.
    Bhora FY, Kothary PC, Imanishi H, Eckhauser FE, Raper SE.
    J Surg Res; 1994 Dec 10; 57(6):706-10. PubMed ID: 7996850
    [Abstract] [Full Text] [Related]

  • 11. Effects of extra- and intracellular pH on vascular action of arginine vasopressin.
    Okada K, Tsai P, Briner VA, Caramelo C, Schrier RW.
    Am J Physiol; 1991 Jan 10; 260(1 Pt 2):F39-45. PubMed ID: 1825151
    [Abstract] [Full Text] [Related]

  • 12. Vasopressin stimulates Ca2+ spiking activity in A7r5 vascular smooth muscle cells via activation of phospholipase A2.
    Byron KL.
    Circ Res; 1996 May 10; 78(5):813-20. PubMed ID: 8620601
    [Abstract] [Full Text] [Related]

  • 13. Linear V1-vascular vasopressin antagonists suitable for radioiodination, biotinylation, and fluorescent labeling.
    Thibonnier M, Bayer AL, Madhun Z.
    Am J Physiol; 1993 Dec 10; 265(6 Pt 1):E906-13. PubMed ID: 8279546
    [Abstract] [Full Text] [Related]

  • 14. Multiple signaling pathways of V1-vascular vasopressin receptors of A7r5 cells.
    Thibonnier M, Bayer AL, Simonson MS, Kester M.
    Endocrinology; 1991 Dec 10; 129(6):2845-56. PubMed ID: 1659517
    [Abstract] [Full Text] [Related]

  • 15. The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.
    Thibonnier M, Preston JA, Dulin N, Wilkins PL, Berti-Mattera LN, Mattera R.
    Endocrinology; 1997 Oct 10; 138(10):4109-22. PubMed ID: 9322919
    [Abstract] [Full Text] [Related]

  • 16. Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from Zucker rats.
    Standley PR, Ram JL, Sowers JR.
    Endocrinology; 1993 Oct 10; 133(4):1693-9. PubMed ID: 8404611
    [Abstract] [Full Text] [Related]

  • 17. Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells.
    Gopalakrishnan V, Xu YJ, Sulakhe PV, Triggle CR, McNeill JR.
    Am J Physiol; 1991 Dec 10; 261(6 Pt 2):H1927-36. PubMed ID: 1836312
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of vascular action of arginine vasopressin by diminished extracellular sodium concentration.
    Okada K, Ishikawa S, Caramelo C, Tsai P, Schrier RW.
    Kidney Int; 1993 Oct 10; 44(4):755-63. PubMed ID: 8258953
    [Abstract] [Full Text] [Related]

  • 19. Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture.
    Ganz MB, Pekar SK, Perfetto MC, Sterzel RB.
    Am J Physiol; 1988 Nov 10; 255(5 Pt 2):F898-906. PubMed ID: 2973244
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of vasopressin-induced increase in intracellular Na+ in vascular smooth muscle cells.
    Okada K, Ishikawa S, Saito T.
    Am J Physiol; 1991 Dec 10; 261(6 Pt 2):F1007-12. PubMed ID: 1661077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.